BTSR yields 200000000.00% · JNJ yields 2.13%● Live data
📍 BTSR pulled ahead of the other in Year 1
Combined, BTSR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTSR + JNJ for your $10,000?
BrightStar Information Technology Group, Inc. provides application engineering services to Global 2000 and midsized companies, and public sector organizations in the United States. It helps organizations in implementing and /or supporting enterprise-level packaged-systems applications and legacy software systems. The company primarily operates in two areas, Enterprise Resource Planning and Legacy Systems. In the Enterprise Resource Planning area, BrightStar implements and /or supports software from SAP, A.G., covering a range of business processes, including finance, human resources, and payroll. It also provides training and other consulting services related to Actuate software, which retrieves business information from corporate databases and delivers it as interactive Web pages and Excel spreadsheets. In the Legacy Systems area, it operates as a subcontractor and supports the fiscal intermediary standard system, which is used to process claims under Medicare Part A. In addition, BrightStar provides e-communication solutions and content management systems to clients in the not-for-profit sector, as well as software support and training services to various corporations. The company was founded in 1997 and is based in Pleasanton, California. BrightStar Information Technology Group, Inc. is a subsidiary of Stellar McKim LLC.
Full BTSR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.